The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.
December 1, 2011|
Editor’s choice in immunology
June 5, 2011|
Pitfalls and triumphs on the way to complete vaccine protection.
April 1, 2011|
Are miRNAs useful for tracking and treating cardiovascular disease?